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Introduction
Cortical interneurons originate in the ganglionic emi-
nences (GEs) in the ventral telencephalon and migrate 
in tangentially oriented streams to enter the cerebral cor-
tex (Marin and Rubenstein 2003; Metin et al. 2006). Here 
they assemble into functional circuits with their pyramidal 
counterparts and contribute to a precise balance of synaptic 
excitation and inhibition. A plethora of factors have been 
identified as regulators of interneuron migration (Faux 
et  al. 2012; Guo and Anton 2014; Marin 2013), but little 
is known about those that determine the choice of stream 
they use to enter the cortex. In order to identify the genes 
involved in migratory stream specification, we compared 
the gene expression profiles of cells in the preplate layer 
(PPL) with those of cells migrating through the interme-
diate zone (IZ) during early corticogenesis. Our analysis 
identified several cadherin family members that showed 
differential expression, including Cdh13 (also known as 
T-cadherin) which was present only in the PPL (Antypa 
et al. 2011).
Cdh13 is an atypical member of the cadherin fam-
ily, devoid of a transmembrane domain and anchored to 
the exterior surface of the plasma membrane via a glyco-
sylphosphatidylinositol (GPI) anchor (Ranscht and Dours-
Zimmermann 1991). It is thought to affect cellular behav-
iour largely through its binding partners and signalling 
properties (Philippova et  al. 2003, 2009). In the human 
central nervous system, CDH13 is found in a variety of 
cell types, including cortical pyramidal and non-pyramidal 
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neurons and astrocytes, and is expressed at lower levels 
in the developing brain than in the adult (Takeuchi et  al. 
2000).
Using an RNAi-based gene silencing approach, Cdh13 
has been shown to play a role in glutamatergic and/or 
GABAergic synapse development in  vitro (Paradis et  al. 
2007) and in the aggregation and neurite outgrowth of cul-
tured motor neurons (Ciatto et al. 2010). Recently, CDH13 
has been associated with hyperactive/impulse symptoms in 
attention deficit hyperactive disorder (ADHD) (Salatino-
Oliveira et  al. 2015). Two other recent studies have shed 
light on the mechanism by which suppression of Cdh13 
function may contribute to ADHD. Firstly, suppression of 
Cdh13 function in lower layer cortical neurons by RNAi 
leads to aberrant axonal projections (Hayano et  al. 2014) 
and, secondly,  Cdh13−/− mice display deficits in learning 
and memory due to alterations in neuron function in the 
hippocampus, similar to that observed in ADHD patients 
(Rivero et al. 2015).
Here we wanted to explore further the roles of Cdh13 
function in cortical development. We observed the pres-
ence of Cdh13 throughout the whole period of corticogen-
esis, with particularly strong expression detected in pyrami-
dal neurons and interneurons at later stages. Analysis of 
 Cdh13−/− mice revealed decreased number of both neuron 
types at E18.5 and a concomitant increase in the level of 
apoptosis, suggesting that Cdh13 plays a critical protective 
role in cell survival at late stages of cortical development.
Materials and methods
Animals
All experimental procedures were performed in accordance 
with the UK Animals (Scientific Procedures) Act 1986 and 
institutional guidelines. Wild-type animals were C57/bl6J 
mice obtained from Charles River Ltd. Cdh13−/− knockout 
(KO) mice and GAD67-GFPneo/− mice were generated as 
described previously (Hebbard et al. 2008; Tamamaki et al. 
2003). The day the vaginal plug was found was considered 
as embryonic day (E) 0.5. Animals of both sexes were used 
in our experiments.
In situ hybridization
For in  situ hybridization and immunohistochemistry, 
embryonic brains were dissected in phosphate-buffered 
saline (PBS) and fixed in 4% paraformaldehyde (PFA), 
made in PBS, for 4–8 h at room temperature (RT). Follow-
ing fixation, embryonic brains were cryoprotected in 30% 
sucrose in Diethyl Pyrocarbonate (DEPC)-treated PBS, 
embedded and frozen in a mixture of 15% sucrose/50% 
Tissue-Tek OCT (Sakura Finetek) and sectioned in the 
coronal plane at 20  µm using a Cryostat (Bright Instru-
ments). Sections were dried at RT for 2 h, before overnight 
incubation at 65 °C in hybridization buffer [1X DEPC-
treated ‘Salts’ (200 mM NaCl, 5 mM EDTA, 10 mM Tris 
pH 7.5, 5  mM  NaH2PO4.2H2O, 5  mM  Na2HPO4; Merck 
KGaA); 50% deionized formamide (Ambion); 0.1  mg/
ml RNAse-free yeast tRNA (Life Technologies); 1x Den-
hardt’s (RNase/DNase free; Life Technologies); 10% dex-
tran-sulphate (Merck KGaA)] containing 100–500  ng/
ml DIG labelled-RNA probes. Probes were generated 
by linearization of plasmids with appropriate enzymes 
and reverse transcription polymerases to obtain antisense 
probes. Probes used were: Cdh13 (provided by B.R.) and 
GAD67 (kindly provided by Dr. Brian Condie, Univer-
sity of Georgia, Georgia, USA). Following hybridization, 
sections were washed 3 times in 50% formamide 1XSSC 
(Ambion) and 0.1% Tween-20 (Merck KGaA) at 65 °C and 
2 times at RT in 1XMABT (20 mM Maleic acid, 30 mM 
NaCl, 0.1% Tween-20; Merck KGaA) before incubating in 
blocking solution [2% blocking reagent (Roche), 10% nor-
mal goat serum (Vector Laboratories) in MABT] followed 
by overnight incubation in alkaline phosphatase-conjugated 
anti-DIG antibody (1:1500; Roche). Nitroblue tetrazolium 
chloride/5-bromo-4-chloro-3-indolyl phosphate (Roche) 
diluted 1:1000 in MABT with 5% polyvinyl alcohol (VWR 
International Ltd) was used for colorimetric detection for 
6  h. Fast Red (Roche) was used for fluorescence colour 
detection of probes by incubation in 100 mM Tris (pH 8.0) 
and 400 mM NaCl containing Fast Red at 37 °C for approx-
imately 2 h. Fluorescent in situ hybridization was followed 
by immunohistochemical detection of GFP as described 
below. Sections were mounted with Glycergel Mounting 
Medium (Dako).
Immunohistochemistry
Embryonic brain sections were washed in PBS, blocked in 
a solution of 5% normal goat serum (Merck KGaA) (v/v) 
containing 0.1% Triton X-100 (v/v) (Merck KGaA) in PBS 
at RT for 2 h. They were first incubated in primary antibod-
ies at RT for 2 h and, then, at 4 °C overnight. The following 
antibodies were used: mouse monoclonal Nestin (1:100, 
DSHB) and 5-Bromodeoxyuridine (BrdU; 1:1000, Pro-
gen), rat monoclonal anti-Ctip2 (1:500, Abcam), chicken 
polyclonal raised against GFP (1:500, Aves Laboratories), 
rabbit polyclonal raised against calbindin (CB-28; 1:3000, 
Swant), cleaved caspase-3 (CC3; 1:250, Cell Signalling 
Technology), Cux1 (1:100, Santa Cruz Biotechnology), 
Cdh13 (1:500, Millipore), L1 (L1; 1:1000, Millipore) or 
phospho-histone H-3 (PH-3; 1:1000, Millipore). Follow-
ing incubation in primary antibodies, sections were washed 
in PBS, incubated in biotinylated anti-species secondary 
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antibodies (1:250; Vector Laboratories) for 2  h and pro-
cessed using conventional immunohistochemistry protocols 
described previously (Andrews et al. 2008).
GAD67 interneuron and Ctip2/Cux1 pyramidal neuron 
counts
In Cdh13 knockout tissues at E15.5 and E18.5, a 300 μm 
segment was measured along the ventricular surface of 
the cortex next to the cortico-striatal junction. A rectan-
gle was then drawn to incorporate the entire thickness of 
the cortex within the 300  μm, and the number of stained 
cells in that box was counted. For interneurons, the num-
ber of GAD67+ cells in each layer was recorded as well as 
the total number of neurons. For Ctip- and Cux1-labelled 
pyramidal cells, counts were only made in their specific 
layers within the boxed region.
Quantification of PH‑3‑positive cells
All PH-3-positive cells present along the entire ventricular 
zone/subventricular zone (VZ/SVZ), from the cortico-stri-
atal junction to the cortical hem (CH), throughout the ros-
tral-caudal extent of the cortex in E15.5 embryonic coronal 
sections were included in all measurements (minimum of 
8 sections from each of 4 animals for each genotype). The 
extent of the layers was determined by methyl green coun-
terstaining (Vector Laboratories). Quantification of apical 
progenitors lining the VZ was presented as PH-3-labelled 
cells per mm. Basal progenitors in the SVZ were presented 
as PH-3-labelled cells per  104 per µm2. Basal progenitors 
here were defined as any cell more than three cells width 
away from the ventricle surface.
Caspase apoptotic cell counts
Sections taken through the brains of Cdh13+/+ and 
Cdh13−/− embryos at E15.5–E18.5 (n = 3 for each geno-
type) were immunostained for CC3. A 300-μm-wide rec-
tangle was then drawn to incorporate the entire thickness of 
the cortex and the number of CC3+ cells in the CP within 
the box was counted. CC3+ blood vessels were excluded 
from the counts.
Plasmids and RNAi constructs
For overexpression experiments, we first generated mouse 
cDNA from E13.5 mouse forebrain mRNA obtained using 
RNAeasy kit (Qiagen) and Superscript III cDNA syn-
thesis kit (Life Technologies). Mouse Cdh13 cDNA was 
produced by PCR amplified using Pfu polymerase (Pro-
mega) [Forward (NheI), GCT AGC GAT GCA GCC GAG 
AAC TCC GCTC; Reverse (HindIII), CCC AAG CTT CAG 
AC-CTG ACA ATA AGC ], digested with NheI and HindIII 
and subcloned into the pCDNA3.1(−) expression vector 
(Promega). For RNAi experiments, we designed three dif-
ferent oligonucleotides, targeting specific regions of mouse 
Cdh13 cDNA [S1 specifically recognizes nucleotides 
278–299; S2, nucleotides 455–476; and S3, nucleotides 
1364–1385] (GenBank accession number NM_019707). 
Three oligonucleotides targeting the corresponding regions 
of mouse Cdh13 cDNA were used in dissociated cell cul-
ture experiments.
Annealed oligonucleotides were cloned in the Gene-
Clip™ U1 Hairpin-hMGFP vector according to the man-
ufacturer’s instructions (Promega). As controls, we used 
short interfering RNAs (siRNAs) targeting the same 
regions, but containing three point mutations and, thus, not 
affecting the stability of Cdh13 mRNA. The efficiency of 
the three different shRNAs in targeting Cdh13 mRNA was 
determined by co-transfection mouse Cdh13 cDNA and the 
different shRNAs at a ratio 1:3, using Lipofectamine 2000 
(Life Technologies) into COS-7 cells. After 48  h, mRNA 
and protein were harvested and level of knockdown was 
determined. mRNA fold change is defined as level of test 
conditioned divided by control (S1m).
QPCR
cDNA from transfected cells and E18.5 interneuron cul-
tures was analysed by qPCR. The qPCR reaction was 
performed with SYBR Green reagent (Merck KGaA) on 
a CFX96™ Real-Time PCR Detector system (Bio-Rad) 
in accordance with manufacturer’s instructions. Primers 
for quantitative real-time PCR (QPCR) were designed by 
Merck KGaA and were as follows: Akt (forward, ATG 
AAC GAC GTA GCC ATT GTG; reverse, TTG TAG CCA 
ATA AAG GTG CCAT); Bcl2 (forward: GTC GCT ACC 
GTC GTG ACT TC; reverse: CAG ACA TGC ACC TAC 
CCA GC), Casp2 (forward, TAC TCC CAC CGT TGA GCT 
GT; reverse, CCG TAG CAT CTG TGG ATA GGC); Cdh13 
(forward, ACC AGC CTG TCC TAA ACT TGA; reverse, 
GCT CCA GAG TTC GGG TGT G); Gapdh (forward, ATG 
ACA TCA AGA AGG TGG TG; reverse, CAT ACC AGG 
AAA TGA GCT TG); Pipa (forward, GAG CTG TTT GCA 
GAC AAA GTTC; reverse, CCC TGG CAC ATG AAT CCT 
GG); Pi3k (forward, ACA CCA CGG TTT GGA CTA TGG; 
reverse, GGC TAC AGT AGT GGG CTT GG). Gapdh and 
Pipa were used for endogenous reference gene controls. 
Each primer set amplified a single PCR product of pre-
dicted size as determined by melt-curve analysis fol-
lowing PCR and by agarose gel electrophoresis and had 
approximately equal amplification efficiencies when 
validated with a serial dilution of representative cDNA. 
Each qPCR was performed in triplicate, and relative 
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quantification was determined according to the DDc(t) 
method (Faux et al. 2010; Livak and Schmittgen 2001).
Western blots
COS7, GN11 cells, or interneurons were lysed in lysis 
buffer (50 mM Tris–HCl, pH 7.4, 150 mM NaCl, 1% 
Nonidet P40). The lysate was incubated at 4 °C for 
30 min and centrifuged for 5 min. Cell lysates were pro-
cessed for conventional SDS–PAGE and membrane trans-
fer. Membranes were incubated with the following rab-
bit polyclonal antibodies:  Phosphoser473-Akt (1:1,000; 
Cell Signalling Technology), Total Akt (1:1000; Cell 
Signalling Technology), β-catenin (1:1000; Abcam), 
Bcl2 (1:1000; Miliore), Cdh13 (1:1000; Miliore), Gapdh 
(1:500; Merck KGaA), Total Gsk3β (1:1000; Cell Signal-
ling Technology),  Phosphoser9-Gsk3β (1:1,000; Cell Sig-
nalling Technology) in 5% BSA-TBST, washed several 
times with TBST and incubated with a horseradish per-
oxidase conjugated secondary antibody (1:5000; Vector 
Laboratories). After intensive washing, the proteins were 
visualized with ECL detection reagent (GE Healthcare).
Dissociated MGE cell cultures
Dissociated cell cultures were prepared from embryonic 
mice as described previously (Cavanagh et  al. 1997). 
Briefly, MGEs were dissected out in cold artificial cer-
ebrospinal fluid (ACSF) under a stereomicroscope. They 
were incubated in Neurobasal medium (Thermo Fisher 
Scientific) containing 0.05% trypsin (Merck KGaA) and 
100 µg/ml DNase I (Roche) at 37 °C for 15 min. Trypsi-
nization was quenched with Neurobasal medium contain-
ing 10% of FBS (Thermo Fisher Scientific) at 37 °C for 
5  min. MGEs were then triturated by pipetting until no 
cellular aggregates were visible. The homogenous cell 
suspensions were subsequently pelleted by centrifugation 
at 1000×g for 3  min. Cells were re-suspended in disso-
ciation media (DM) [DMEM/F12 culture media contain-
ing B27 supplement, 100  µg/ml penicillin/streptomycin 
and 2 mM L-glutamine (Thermo Fisher Scientific)], and 
100,000 cells were seeded onto 13 mm coverslips coated 
previously with 10  µg/ml poly-l-lysine and 10  µg/ml 
laminin (Merck KGaA) and incubated in a humidified 
incubator at 37 °C. The culture medium was changed the 
next day.
For cell signalling experiments, E15.5 MGE cell cul-
tures were prepared, and the next day fresh DM was added, 
containing either 2 µg/ml human IgG or 2 µg/ml Cdh13-Fc, 
and left for 2 DIV. Cells were then processed either for 
immunohistochemistry, Western blotting or qPCR.
Chemotaxis assays
Chemotaxis assays were performed using a 48-well 
Boyden’s chamber (Neuro Probe) as described previ-
ously (Hernandez-Miranda et  al. 2011). Briefly, 27  µl 
of DM containing 1% FBS were placed into the lower 
compartment of the chamber. Dissociated MGE or GN11 
cells were re-suspended in serum-free medium  (105 
cells/50 µl) and placed in wells of the upper compartment 
of the chamber in the presence of anti-Cdh13 antibody 
(2 µg/ml, R&D Systems) or rabbit serum (Merck KGaA). 
These were separated from the lower chamber by a poly-
carbonate porous membrane (8  µm pores), pre-coated 
with gelatin (0.2  mg/ml) for GN11 cells and laminin 
(10  µg/ml), plus either 1  µg/ml human IgG (Merck 
KGaA) or 1 µg/ml Cdh13-Fc (R&D Systems). For GN11 
cells, the chamber was kept in an incubator at 37 °C for 
4 h (GN11 cells) or overnight (MGE cells). After incuba-
tion, the migrated cells that adhered to the underside of 
the membrane were fixed and stained using the Diff-Quik 
kit (Reagena). For quantitative analysis, the membranes 
were observed using an Olympus light microscope with 
a 20× objective adapted with a 500 × 500 µm grid. Four 
random fields of stained cells were counted for each well, 
and the mean number of migrating cells per square milli-
metre for each experimental condition was estimated.
Proliferation/apoptosis experiments
48  h after transfection with overexpression and knock-
down constructs, primary cells were washed, fixed with 
4% PFA, immunostained for PH-3 and nestin to identify 
progenitors, and EGFP to identify transfected cells. For 
analysis of apoptosis in interneuron cultures, CC3 and 
CB immunohistochemistry was carried out. Cell counts 
were made using a ×40 objective lens in 9 fields of view 
for each sample. At least three samples were evaluated 
for each time point and treatment. For overexpression 
constructs, the controls were cells that had been trans-
fected with empty pcDNA3.1 (Life Technologies) vector. 
For knockdown constructs, the controls were cells that 
had been transfected with mutated siRNA constructs in 
the same pGeneClip™ hMGFP vector. The percentage 
of proliferating cells was determined using the following 
equation: total number of EGFP-nestin double-labelled 
cells divided by the number of PH3+- EGFP-nestin triple 
positive cells multiplied by 100. To calculate the percent-
age of apoptotic interneurons in the cultures, we used the 
following equation: total number of EGFP+-CB+ cells 
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divided by the number of CC3+-EGFP+-CB+ cells mul-
tiplied by 100.
Digital image acquisition and processing
Optical and fluorescent images were collected using Leica 
Microsystems light- or confocal microscopes. Images were 
reconstructed and digitized with Photoshop CS2 software 
(Adobe Systems).
Statistics
All data are reported as mean number and SEM. Statistical 
analysis was performed with GraphPad 3 (GraphPad Soft-
ware). A one-way ANOVA was used to evaluate the fit of 
the data to a normal distribution and, then, Student’s t test 
was used to evaluate paired comparisons. Significant differ-
ences were considered when p < 0.05.
Results
Expression of Cdh13 in the developing forebrain
Little is known about the expression of Cdh13 in the 
embryonic rodent telencephalon. Earlier expression studies 
were performed in other species and, for the most part, at 
later ages than at key stages of cortical interneuron devel-
opment (Matsunaga et  al. 2013; Ranscht and Dours-Zim-
mermann 1991; Takeuchi et al. 2000). Thus, we undertook 
an extensive analysis of Cdh13 expression at early (E13.5), 
middle (E15.5) and late (E18.5) stages of mouse embry-
onic cortical development using in  situ hybridization and 
immunohistochemistry.
At E13.5, Cdh13 mRNA expression shows a gradient 
within the PPL being highest at the level of the cortico-
striatal junction and lowest in the hippocampus (Fig. 1a–c); 
this is in agreement with our previous microarray study 
(Antypa et  al. 2011). In the basal telencephalon, Cdh13 
mRNA is expressed weakly in the preoptic area (POA). 
At E15.5, it is expressed strongly in the cortical plate (CP) 
with a weaker, secondary band alongside the upper IZ 
that increases in strength from the cortico-striatal junc-
tion (Fig. 1d–f). Its expression in the basal telencephalon at 
this stage appears to have expanded too, extending further 
ventrally, particularly in the region of the lateral ganglionic 
eminence (LGE) where it now encompasses the developing 
striatum (Str) (Fig. 1d–f).
By E18.5, expression in the cortex becomes much 
broader, extending from the CP, across the IZ and into 
the upper SVZ. In addition, within this band, there are 
stripes of strong expression in the SVZ, IZ and low-mid 
CP/subplate (SP) (Fig.  1g–i). Expression is particularly 
strong in the Str in the basal telencephalon. Our finding 
that Cdh13 expression increases as development proceeds 
in the cortex concurs with the recent study of Rivero 
et al. (2015).
In the cortex, Cdh13 is present in layers through which 
interneurons migrate, suggesting it may be expressed in 
these migrating cells. To confirm this, we carried out 
fluorescent in situ hybridization in GAD67-GFP mice, in 
which all interneurons express green fluorescent protein 
(Tamamaki et  al. 2003). At E13.5, the staining appears 
to begin just underneath the PPL migratory stream and 
extends halfway towards the one at the level of the IZ 
(Fig.  2a–c, hollow arrowheads indicate the positions 
of migratory streams). By E15.5, Cdh13 is strongly 
expressed in the CP, and delineates the region between 
the interneuron migratory streams of the SP and marginal 
zone (MZ) (Fig. 2d–f). At higher magnification, interneu-
rons in the SP and CP do not express Cdh13 mRNA 
(arrowheads in Fig.  2j, j″). At E18.5, expression of the 
cadherin has broadened, encompassing most cortical lay-
ers and appears to co-localize in some interneurons in 
the SVZ and IZ (open arrowheads in Fig. 2h) and when 
examined at higher magnification, in a few cells in the CP 
(open arrowheads in Fig. 2k, k″).
To confirm these findings, we carried out immunohisto-
chemistry in GAD67-GFP mice for Cdh13 protein through-
out the period of corticogenesis. At early to middle stages, 
the distribution of the protein mirrors that of the mRNA. 
At E13.5 there was strong yellow staining within the PPL, 
indicating co-localization (hollow arrowhead in Fig. 3a–c). 
However, on closer examination, this appears to be in blood 
vessels within the meninges (data not shown). At E15.5, 
there is strong staining in the CP, most likely in pyrami-
dal neurons, and in the IZ concurrent with the in situ data 
(Fig. 3d–f); it is also present in the SP. Strong staining in 
the ventral telencephalon occurs only in the rostral portion 
and is seen in the germinal zones and the POA (Fig. 3d). 
At E18.5, Cdh13 protein expression pattern is strikingly 
different from the mRNA, where staining appears to be 
spread relatively evenly throughout all cortical layers 
(Fig. 3g–i). This ubiquity in staining is perhaps unsurpris-
ing, given the very broad Cdh13 mRNA expression at this 
age. High-power confocal microscopy of sections at E18.5 
shows punctate expression in a number of interneurons (see 
arrowheads Fig. 3j″), which is similar to that observed in 
human vascular smooth muscle cells (Philippova et  al. 
2003) and, more recently, in adult mouse hippocampal 
interneurons (Rivero et  al. 2015). Our expression analy-
sis throughout the period of corticogenesis has shown that 
Cdh13 is not expressed within proliferative zones in the 
developing forebrain, but is present within pyramidal neu-
rons and some interneurons during mid-late stages of corti-
cal development.
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Fig. 1  In situ hybridization for Cdh13 mRNA in the developing 
forebrain. Coronal sections through the developing mouse forebrain 
at E13.5 (a–c), E15.5 (d–f) and E18.5 (g–i) showing localization of 
Cdh13 expression at rostral (a, d, g), medial (b, e, h) and caudal (c, 
f, i) levels. Scale bar in a, 500 μm, applicable to all images. CH cor-
tical hem, CP cortical plate, IZ intermediate zone, LGE lateral gan-
glionic eminence, MGE medial ganglionic eminence, POA preoptic 
area, PPL preplate layer, Str striatum, SP subplate, SVZ subventricu-
lar zone
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Fig. 2  Fluorescence in situ 
hybridization for Cdh13 mRNA 
in the developing forebrain. 
Coronal sections from GAD67-
GFP mouse forebrains at E13.5 
(a–c), E15.5 (d–f) and E18.5 
(g–i) showing Cdh13 expression 
(red) at rostral (a, d, g), medial 
(b, e, h) and caudal (c, f, i) 
levels. Hollow arrowheads indi-
cate the positions of migratory 
streams of cortical interneurons. 
j–k″) Higher power images at 
E15.5 (j, j″) and E18.5 (k, k″); 
arrowheads indicate examples 
of interneurons that express 
Cdh13 mRNA (see insets). 
Scale bar in a 500 μm (a–i); in 
j 50 μm (j, j″); in k 75 μm (k, 
k″). CP cortical plate, IZ inter-
mediate zone, LGE lateral gan-
glionic eminence, MGE medial 
ganglionic eminence, MZ 
marginal zone, PPL preplate 
layer, SP subplate, Str striatum, 
SVZ subventricular zone
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Altered number of neurons in the cortex of Cdh13−/− 
mice
Using in  situ hybridization for GAD67, we assessed the 
number and position of interneurons within the developing 
cortex of Cdh13+/+ and Cdh13−/− mice at middle (E15.5) 
and late (E18.5) stages of development (n = 5 for each gen-
otype), at a time when expression of the gene was noted in 
these cell types. At E15.5, we did not observe any statisti-
cally significant differences in the total number of GAD67+ 
cells (Cdh13+/+ 129.75 ± 16.4; Cdh13−/− 101.89 ± 13.3; 
p < 0.2) (Fig. 4c). These observations were confirmed using 
immunohistochemistry for the interneuron marker cal-
bindin (CB) (Anderson et  al. 1997) (data not shown). To 
assess potential positioning defects, we quantified the rela-
tive numbers of GAD67+ cells in each cortical layer as a 
percentage of the total number of neurons for each geno-
type. This analysis showed that loss of Cdh13 had no sig-
nificant effect on their position within the cortex (Fig. 4d).
Analysis at a later phase of corticogenesis (E18.5) 
revealed a significant decrease in the total num-
ber of GAD67+ cells in the middle regions (along 
the rostral–caudal axis) of the cortex of (Cdh13+/+ 
169.56 ± 5.49; Cdh13−/− 109.37 ± 4.87; p < 0.0002), 
particularly in the CP (Cdh13+/+ 63.03 ± 1.59; 
Cdh13−/− 35.78 ± 1.86; p < 0.0003), SVZ/IZ (Cdh13+/+ 
48.95 ± 1.37; Cdh13−/− 28.28 ± 0.94; p < 0.0009) and MZ 
(Cdh13+/+ 30.21 ± 0.98; Cdh13−/− 24.42 ± 0.77; p < 0.02) 
(Fig.  4g). When we assessed position of GAD67+ cells 
within the developing cortex of Cdh13−/− mice, we 
observed a small but significant shift of cells from the CP 
(Cdh13+/+ 37.17 ± 1.91; Cdh13−/− 32.71 ± 1.82; p < 0.04) 
to the MZ (Cdh13+/+ 17.82 ± 1.78; Cdh13−/− 22.33 ± 1.59; 
p < 0.04) compared to Cdh13+/+ littermates (Fig. 4h).
To assess whether this effect is specific to interneu-
rons within the cortex, we immunostained coronal sec-
tions from Cdh13+/+ mice and Cdh13−/− littermates for 2 
pyramidal markers, Ctip2-[early born, lower layer (Arlotta 
et al. 2005)] and Cux1 (late born, upper layer Cubelos et al. 
2010). At E15.5, we did not observe any statistically signif-
icant differences in the total number of Ctip2-positive cells 
in the cortex of Cdh13−/− mice (Cdh13+/+ 393.57 ± 15.26; 
Cdh13−/− 361.42 ± 14.52; p < 0.34) nor at E18.5 (Cdh13+/+ 
199.09 ± 19.87; Cdh13−/− 161.2 ± 28.18; p < 0.57) (see 
Fig. 4e, f, k). However, at this later age, we found a marked 
decrease in the number of  Cux1+ neurons (Cdh13+/+ 
218.54 ± 12.82; Cdh13−/− 110.25 ± 23.67; p < 0.01) 
(Fig.  4i–k). The reduction in the number of interneu-
rons and pyramidal cells in the cortex of Cdh13−/− mice 
could be due to a number of factors, including defects in 
migration into the cortex, reduced proliferation and/or an 
increase in apoptosis or a combination of all three.
Interneuron migration in the cortex of Cdh13−/− mice
A previous study has shown a role for Cdh13 in cell migra-
tion. Specifically, transfection of CDH13 siRNA constructs 
into a human bladder carcinoma cell line significantly pro-
moted the migration of these cells compared with controls 
(Lin et al. 2013). Based on this finding, we would predict 
increased migration and a greater number of interneurons 
in the developing cortex of Cdh13−/− mice. However, at 
E15.5, we did not see any significant changes in the num-
ber of interneurons in the cortex, which would suggest that 
their migration is probably unaffected in Cdh13−/− mice. 
This finding was confirmed in in  vitro knockdown stud-
ies using immortalized gonadotropin-releasing hormone 
secreting (GnRH) neurons (GN11 cells), where we failed 
to observe an effect on migration, suggesting that Cdh13 
is unlikely to play a direct role in neuronal migration 
(Fig. 7c).
A number of studies have reported that interneurons use 
axonal projections to migrate from the ventral telencepha-
lon to the cortex (Denaxa et al. 2001; McManus et al. 2004; 
Morante-Oria et  al. 2003; Parnavelas 2000). While such 
an association was not supported by another study (Tan-
aka et  al. 2003), knockdown of CXCL12 expression was 
recently shown to result in impaired axonal development 
and perturbed interneuron migration (Abe et  al. 2015). 
These data suggest that axonal tracts in the cortex may be 
involved in interneuron migration after all. Interestingly, 
our expression analysis here seems to show that axonal 
tracts in the IZ express Cdh13 (Fig. 3e). To investigate an 
association between interneurons and axonal tracts within 
the developing forebrain and expression of Cdh13 in these 
axons, we carried out immunohistochemistry for CB, the 
thalamocortical axonal marker L1 and Cdh13. We found 
at E15.5, in agreement with previous studies (Parnavelas 
2000; Denaxa et al. 2001), that many processes of migrat-
ing interneurons were in close association with axons in the 
IZ (arrows in Fig. 5a). Double labelling experiments for L1 
and Cdh13 at E15.5 and E18.5 showed that thalamocortical 
axonal projections express both markers (Fig. 5b, c), sug-
gesting that interneurons may use these Cdh13 expressing 
axons in their journey from the ventral to dorsal forebrain. 
Fig. 3  Expression of Cdh13 protein in cortical interneurons. Coronal 
sections from GAD67-GFP mouse forebrains at E13.5 (a–c), E15.5 
(d–f) and E18.5 (g–i), were immunostained for Cdh13 (red) at rostral 
(a, d, g), medial (b, e, h) and caudal (c, f, i) levels. At E15.5 and 
E18.5, co-localization (yellow) is observed in the SP and CP. Hollow 
arrowheads indicate the positions of migratory streams of cortical 
interneurons. j, j″ Higher power images at E18.5; arrowheads indi-
cate examples of interneurons that express Cdh13 protein (see inset). 
Scale bar in a 500  μm (a–i), in j 75  μm (j, j″). CP cortical plate, 
LGE lateral ganglionic eminence, MGE medial ganglionic eminence, 
MZ marginal zone, PPL preplate layer, SP subplate
◂
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Thus, any alterations in the thalamocortical and cortico-
thalamic axonal projections may affect interneuron migra-
tion (Abe et  al. 2015; Andrews et  al. 2006; Denaxa et  al. 
2001) and, thus, explain the observed decrease in cortical 
interneurons in Cdh13−/− mice.
To assess the development of axonal tracts, we carried 
out immunohistochemistry for L1 at E15.5 and E18.5 in 
Cdh13+/+ and Cdh13−/− littermates (n = 3 for each geno-
type). No gross differences were observed at either age 
in the development of axonal tracts (thalamocortical 
and corticothalamic) in Cdh13−/− compared to controls 
(Fig. 5d–g). However, as Cdh13-mediated de-adhesion can 
facilitate human aortic smooth muscle (SMC) and human 
umbilical vein endothelial (HUVEC) cell migration in a 
Boyden’s chamber assay (Ivanov et al. 2004b), we reasoned 
that Cdh13 expressed on axonal tracts could assist in the 
migration of interneurons. Consequently, loss of Cdh13 
function would perturb the migration process and poten-
tially explain why we see fewer cortical interneurons in the 
Cdh13−/− mice.
To test this idea, we mimicked interneuron migration 
along Cdh13 expressing axons in Boyden’s chamber assay 
experiments using E17.5 cortical interneurons and mem-
branes coated either with Cdh13-Fc protein or human IgG, 
in the presence or absence of a Cdh13 blocking antibody. 
No significant differences were observed in the migration 
of interneurons on membranes coated with human IgG, 
compared to those coated with Cdh13-Fc protein (IgG 
5857 ± 670 cells/mm2; Cdh13-Fc 5869 ± 309 cells/mm2, 
p > 0.63) (Fig.  5h). Addition of blocking antibody also 
failed to have a significant effect on migration, either on 
IgG or Cdh13-coated membranes compared to controls, 
suggesting that blocking Cdh13 function in interneurons 
and/or its substrate does not perturb migration. These find-
ings are in agreement with our E15.5 cortical interneuron 
counts, where we failed to observe a change in interneuron 
numbers in the cortex, implying migration was unaffected 
by loss of Cdh13 function. Taken together, our data do not 
provide evidence for a role of Cdh13 in cortical interneuron 
migration.
Altered proliferation in the developing forebrain 
of Cdh13−/−mice
A previous study demonstrated that expression of Cdh13 
in neuroblastoma cells resulted in their inability to respond 
to epidermal growth factor-induced proliferation, indicat-
ing it functions as a negative regulator of neuronal cell 
growth (Takeuchi et  al. 2000). Based on these in  vitro 
observations, we would predict that loss of Cdh13 func-
tion would result in increased proliferation and more 
interneurons, not fewer, as observed here. To assess pro-
liferation in these mice, we immunostained coronal sec-
tions from E15.5 Cdh13−/− mice and wild-type littermates 
Fig. 4  Reduced number of interneurons and pyramidal cells in the 
cortex of Cdh13−/− mice. Images of in situ hybridization for GAD67 
(a, b) and immunohistochemistry for Ctip2 (e, f), Cux1 (i, j) and CC3 
(m, n) in coronal sections through the cortex of Cdh13+/+ (a, e, i, m) 
and Cdh13−/− (b, f, j, n) mice at E18.5. Analysis of the number of 
GAD67 labelled cells in all layers of the cortex at E15.5 (c) and E18.5 
(g) as well as their relative distribution compared to wild-type litter 
mates at both ages (d, h). k Quantification of Ctip2 and  Cux1+ cells 
in the cortex of Cdh13−/− animals showed reduced numbers of the 
latter only at E18.5 when compared to Cdh13+/+ controls. l Quanti-
fication of the number of CC3+ cells in the CP (black arrows in m, 
n) showed an increase in the cortex of Cdh13−/− mice compared to 
Cdh13+/+ controls at E18.5 [CC3+ blood vessels (white arrows in 
m, n, were excluded from counts)]. o Reduced cortical thickness 
was observed in the cortex of Cdh13−/− animals at E18.5 when com-
pared to Cdh13+/+ controls, to coincide with the decreased number 
of neurons. Scale bars in a 200 µm, in e 100 µm and in m 150 µm. 
(*p < 0.01, ***p < 0.0001). Error bars indicate SEM. CP cortical 
plate, IZ intermediate zone, LCP lower CP, MZ marginal zone, SVZ 
subventricular zone, UCP upper CP, VZ ventricular zone
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Fig. 5  Normal axonal 
development in the cortex of 
Cdh13−/− mice. Coronal sec-
tions from wild-type mouse 
forebrains at E15.5 (a, b) and 
E18.5 (c) were immunostained 
for L1 (a–c), CB (a) or Cdh13 
(b, c). At E15.5, interneuron 
processes appear to be in close 
contact with axons in the IZ 
(arrows in a) and, at E15.5 
and E18.5, co-localization 
(yellow) is seen between L1 
and Cdh13 in the IZ. Coronal 
brain sections from Cdh13+/+ 
(d, f) and Cdh13−/− (e, g) 
mice at E15.5 (d, e) and E18.5 
(f, g) were immunostained 
for L1. No gross differences 
were observed in axonal tract 
development. h Quantification 
of MGE cell migration in a 
Boyden’s chamber assay with 
membrane coated with human 
IgG or Cdh13Fc protein in the 
presence or absence of Cdh13 
blocking antibody. Histogram 
shows coating membranes with 
Cdh13 protein or the addition 
of Cdh13 antibody does not 
affect interneuron migration. 
i, j Histograms indicate the 
presence of a significantly 
greater number of mitotically 
active (PH-3+) apical (VZ) 
and basal (SVZ) progenitors 
in the MGE of Cdh13−/−mice 
at E15.5 compared to controls, 
but not in the cortex. Scale bar 
in a 100 µm, and in d 200 µm. 
Histograms show mean values 
and error bars represent SEM; 
**p < 0.001. IZ intermediate 
zone, CP cortical plate, CA 
callosal axons, LGE lateral gan-
glionic eminence, SP subplate
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(n = 3 for each genotype) for the mitotic marker PH-3. 
Analysis revealed a significant increase in the number 
of MGE PH-3+ cells in the VZ (Cdh13+/+ 2.5 ± 0.161; 
Cdh13−/− 3.6 ± 0.16, per 100  µm; p < 0.00008) and SVZ 
(Cdh13+/+ 31.45 ± 1.98; Cdh13−/− 42.6 ± 2.26 4 × 104 µm2; 
p < 0.0009), but no changes in the cortical VZ (Cdh13+/+ 
7.01 ± 0.445; Cdh13−/− 7.42 ± 0.4 per 100  µm; p < 0.506) 
or SVZ (Cdh13+/+ 26.64 ± 2.54; Cdh13−/− 26.75 ± 1.26 
4 × 104 µm2; p < 0.097) (Fig. 5i, j). While these data fit our 
prediction of increased number of proliferating progenitors 
in Cdh13−/− mice, they do not explain why we find fewer 
cortical interneurons at E18.5.
Increased apoptosis in the developing forebrain 
of Cdh13−/−mice
A previous study demonstrated that up-regulation of 
Cdh13 protects endothelial cells from endoplasmic reticu-
lum stress-induced apoptosis (Kyriakakis et  al. 2010). 
Thus, here we reasoned that loss of Cdh13 function may 
lead to increased apoptosis. When we stained E18.5 sec-
tions for the apoptotic marker-cleaved caspase 3 (CC3), 
we did indeed observe a significant increase in the number 
of apoptotic cells in the CP of Cdh13−/− mice (Cdh13+/+ 
5.2 ± 0.92; Cdh13−/− 15.87 ± 1.53; p < 0.0004) (Fig. 4l–n). 
As a result of increased apoptosis and reduced neu-
ronal numbers in the cortex of Cdh13−/− mice, we found 
a corresponding decrease in cortical thickness at E18.5 
(Cdh13+/+ 700.9 ± 25.97 µm; Cdh13−/− 620.72 ± 20.75 µm; 
p < 0.0001), but not at E15.5 (Cdh13+/+ 498.57 ± 6.67 µm; 
Cdh13−/− 507.62 ± 7.66  µm; p < 0.64) (Fig.  4o). Taken 
together, our data indicate that loss of Cdh13 function 
results in increased apoptosis and a concomitant reduction 
in the number of  Cux1+ neurons and cortical interneurons 
late in development.
Loss of Cdh13 function affects apoptosis in neuronal 
cultures
To assess whether the defects observed in Cdh13 knockout 
mice is cell-autonomous, we decided to apply the RNAi 
technique to investigate the role(s) of this gene in cortico-
genesis. We designed three RNAi sequences (called S1–S3) 
that target three different regions within Cdh13 mRNA 
(Fig. 6a). To test the effectiveness of our siRNA constructs 
on Cdh13 expression, we transfected COS-7 cells with the 
overexpression and either knockdown or mutated siRNA 
constructs (at a ratio of 1:3). 48  h after transfection, we 
assessed the level of Cdh13 mRNA and protein in these 
cells. We observed a significant reduction in both Cdh13 
mRNA and protein with knockdown constructs, but not 
with mutated sequences (Fig. 6b, c).
To examine the effects of overexpression or silencing of 
Cdh13 on cell proliferation and apoptosis, Cdh13 cDNA or 
Fig. 6  Suppression of Cdh13 expression increases apoptosis in 
interneurons. a Sequences of specific and triple-point-mutated (high-
lighted in bold) siRNAs targeting mouse Cdh13 mRNA. b, c COS-7 
cells were transfected with Cdh13expression plasmid and different 
siRNA constructs. Two days after transfection, cell lysates were sub-
jected to quantitative PCR (b) and Western blot analysis using Cdh13 
antibody (c). Cdh13 levels in cells transfected with specific siRNAs 
(S1, S2) were significantly lower than those in cells transfected with 
triple-point-mutated siRNAs (S1m). Quantitation of proliferating 
(PH-3+) (d) and apoptotic (CC3+) (e) cells in E14.5 (d) and E17.5 
(e) MGE cultures 2DIV after transfection with Cdh13 overexpres-
sion and knockdown constructs. Error bars indicate SEM (*p < 0.01, 
***p < 0.0001)
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control (pCDNA3.1) and S1 siRNA(GFP) or mutated Sl 
siRNA(GFP) (S1m) were introduced into E14.5 rat MGE 
(equivalent to mouse E12.5) neural progenitors in order to 
examine proliferation or into E17.5 (equivalent to mouse 
E15.5) MGE cultures to assess apoptosis. After 2 days 
in  vitro (2 DIV), cells were stained for nestin (neuronal 
progenitor) and PH-3 (proliferative) to assess proliferation 
or CB (interneuron) and CC3 (apoptotic) markers to iden-
tify apoptotic interneurons (see methods section for more 
details). Overexpression of Cdh13 did not have an effect on 
either proliferation (pCDNA3.1 73.98 ± 4.24% (EGFP/nes-
tin/PH3 positive cells), Cdh13 66.43 ± 5.03%, p < 0.36) or 
apoptosis (pCDNA3.1 18.01 ± 7.43% (EGFP/CB/CC3 posi-
tive cells), Cdh13 24.6 ± 6.84%, p < 0.54) compared to con-
trol cultures (Fig.  6d, e). While Cdh13 knockdown had a 
small, but significant effect on proliferation within our neu-
ronal progenitor cultures (S1m 72.64 ± 2.25% (EGFP/nes-
tin/PH3 positive cells), S1 63.94 ± 3.5%, p < 0.017), it dra-
matically increased the level of apoptosis in our interneuron 
cultures (S1m 23.15 ± 7.5% (EGFP/CB/CC3 positive cells), 
S1 77.38 ± 9.25%, p < 0.0007) compared to controls, which 
is in agreement with our knockout mouse studies.
To further characterize the putative role of Cdh13 
in migration, proliferation and apoptosis, we wanted to 
determine whether the observed increase in cell death was 
specific to cortical interneurons or whether it applied to 
other migrating neuronal cell types. In earlier studies, we 
had used GN11 cells to examine the effects of factors on 
migration (Hernandez-Miranda et al. 2011) and on prolif-
eration/apoptosis (Cariboni et al. 2011). Here, we explored 
whether GN11 cells also possess Cdh13 receptors and 
assessed the role of the cadherin on migration, proliferation 
and survival. We found that GN11 cells, like interneurons, 
expressed mRNA for Cdh13 by reverse transcription-PCR 
(Fig. 7a) and by immunohistochemistry (Fig. 7b). We next 
examined the effects of overexpression and knockdown of 
Cdh13 on GN11 cell migration using a Boyden’s chamber 
assay. Cells were cultured in the absence (negative control) 
or presence of 1% serum, which has a positive effect on 
migration (Cariboni et  al. 2007). When we compared the 
percentage increase in migration following serum treatment 
on the different cell populations, we observed no significant 
differences in their migratory ability compared to controls 
(pCDNA3.1 144 ± 10.1%, Cdh13 ovx 137.49 ± 8.04%, 
p < 0.409; S1m 145.86 ± 14.1%, S1 139 ± 14.22%, p < 0.96) 
(Fig.  7c). In terms of proliferation, we observed a small 
but significant decrease in PH-3+ cells following overex-
pression, but not knockdown of Cdh13 levels (pCDNA3.1 
Fig. 7  Suppression of Cdh13 expression in GN11 affects prolif-
eration and apoptosis. a Reverse transcription (RT)-PCR analysis 
showed expression of Cdh13 in GN11 cells. b Immunohistochemistry 
confirmed the expression of Cdh13 receptor in GN11 cells. c Quan-
tification of GN11 cell migration in a Boyden’s chamber following 
transfection with either Cdh13 overexpression, knockdown or control 
constructs showed that migration is unaffected by perturbing Cdh13 
expression. Histograms show percentage of proliferating (GFP+/
PH-3+) (d) and apoptotic (GFP+/CC3+) (e) cells following trans-
fection with either overexpression, knockdown or control constructs. 
Scale bar in b 250 µm. (*p < 0.01, **p < 0.001). Error bars indicate 
SEM
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70.57 ± 5.44%, Cdh13 ovx 47.74 ± 7.43%, p < 0.007; S1m 
52.14 ± 8.85%, S1 64.18 ± 9.75%, p < 0.48) (Fig. 7d). These 
findings are in agreement with our E15.5 knockout mouse 
data, where we failed to observe any significant changes in 
the number of interneurons in the cortex or in their migra-
tion. However, when we examined the levels of apoptosis 
in our cultures following serum starvation, we observed 
overexpression of Cdh13 resulted in a dramatic decrease 
(pCDNA3.1 70.78 ± 3.34%, Cdh13 ovx 45.41 ± 8.5%, 
p < 0.002) and, conversely, knockdown increased the 
level of apoptosis (S1m 70.22 ± 3.28%, S1 82.39 ± 4.09%, 
p < 0.011) in GN11 cells (Fig. 7e), which is in agreement 
with our primary interneuron cultures.
Cdh13 plays a protective role in neuronal development 
via the Pi3k/Akt pathway
Previously, it has been shown in endothelial cells that 
Cdh13 is up-regulated in response to oxidative stress, and 
adenovirus-mediated overexpression protects against oxi-
dative stress-induced apoptosis (Joshi et  al. 2005). This 
study also demonstrated that Cdh13-promoted survival was 
associated with concomitant activation of the Pi3-kinase/
Akt survival signalling pathway. To assess if this path-
way is affected in GN11 cells following overexpression 
and knockdown of Cdh13, we carried out Western blot 
analysis. We found that overexpression of Cdh13 increased 
the level of  Pser473-Akt (pCDNA3.1 100 ± 8.8%, Cdh13 
ovx120.76 ± 6.8%, p < 0.05) and  Pser9-GSK3β (pCDNA3.1 
100 ± 7.3%, Cdh13 ovx 181.35 ± 8.9%, p < 0.0001). Cdh13 
knockdown had the opposite effect, resulting in a decrease 
in the levels of both proteins  (Pser473-Akt S1m 100 ± 5.2%, 
S1 46.13 ± 8.2%, p < 0.0001;  Pser9-GSKβ S1m 100 ± 8.4%, 
S172.23 ± 6.5%, p < 0.0001) compared to controls (Fig. 8a, 
c), suggesting that the survival pathway is deactivated fol-
lowing the loss of Cdh13 function.
Cdh13 was recently shown to function as a pro-apoptotic 
tumour suppressor that antagonises AKT/CREB/AP-1/
FOX03a signalling in melanoma cells (Bosserhoff et  al. 
2014). To assess if this pathway was affected, we looked at 
the expression of downstream targets of FOX03a, the anti-
apoptotic marker Bcl2 and the apoptotic marker CC3. Our 
Western blot analysis showed that the level of Bcl2 was 
reduced following Cdh13 knockdown (S1m 100 ± 4.9%, 
S1 30.19 ± 4.8%, p < 0.0001), while there was a concomi-
tant increase in the level of CC3 (S1m 100 ± 5.2%, S1 
118.51 ± 4.7%, p < 0.0001), which is in agreement with our 
previous observations (Fig. 8b, d).
Cdh13 overexpression has been shown to increase 
cell cycle progression and proliferation of HUVEC cells 
(Ivanov et al. 2004a), and ILK-GSK3β signalling via Cdh13 
has been shown to modulate active (non-phosphorylated) 
β-catenin levels and downstream proliferation events in 
endothelial cells (Joshi et  al. 2007). To assess further if 
proliferation was affected following Cdh13 knockdown in 
GN11 cells, we carried out Western blot analysis for active 
β-catenin. Active β-catenin levels were reduced following 
Cdh13 knockdown (S1m 100 ± 9.1%, S1 76.08 ± 7.2%, 
p < 0.001), which is in agreement with our PH-3 interneu-
ron progenitor proliferation experiments (Fig. 6d).
To assess if these pathways were affected in interneu-
rons following inactivation of Cdh13 function, we incu-
bated E16.5 MGE interneuron cultures with either a domi-
nant negative form of Cdh13 (Cdh13-Fc) or control human 
IgG protein (2  µg/m; each) for 2DIV, and then examined 
the levels of mRNA and protein. The mRNA levels of 
Akt, Pi3k and Bcl2 were all significantly lower following 
treatment with the dominant negative form of Cdh13 (Akt, 
−8.68 ± 1.05, p < 0.0001; Pi3k, −3.69 ± 0.174, p < 0.001; 
Bcl2, −1.36 ± 0.12 fold change), while levels of Casp2 
were considerably higher (Casp2, 2.77 ± 0.69 fold change, 
p < 0.001) compared to control-treated interneuron cul-
tures (Fig.  8e). Similar changes were observed in protein 
levels with reduced amounts of total Akt (77.45 ± 7.3%, 
p < 0.001),  Pser473-Akt (11.2 ± 3.63, p < 0.0001), Pi3k 
(37.8 ± 5.3%, p < 0.0001) and Bcl2 (85.14 ± 4.7%, 
p < 0.01), and increased levels of Casp2 (118.97 ± 8.2%, 
p < 0.001) compared to control-treated cells (Fig.  8f, g). 
Taken together, the in vitro and knockout data suggest that 
Cdh13 plays a protective role in neuronal development by 
acting through the Pik3/Akt pathway.
Discussion
The origins and migratory routes of cortical interneurons 
in rodents are now well documented. Tracing studies have 
confirmed that the majority of these cells arise in MGE 
in the ventral telencephalon and migrate in tangentially 
oriented streams to enter the cortex (Marin and Ruben-
stein 2003; Metin et  al. 2006). Once in the cortex, they 
leave their migratory streams to assume positions in the 
CP where they assemble into functional circuits with their 
pyramidal counterparts, contributing to a precise balance of 
synaptic excitation and inhibition in this region. It has been 
suggested that disruption of this balance results in neuro-
logical conditions such as epilepsy, Parkinson’s disease 
(Cobos et  al. 2005; Kumar and Buckmaster 2006; Mallet 
et  al. 2006; Sloviter 1987) and attention deficit hyperac-
tivity disorder (ADHD) (D’Agati et  al. 2014; Purkayastha 
et  al. 2015). Several studies have linked disruptions in 
CDH13 function with susceptibility to ADHD. In particu-
lar, a single nucleotide polymorphism in CDH13 has been 
linked with altered performance in certain memory tests in 
ADHD sufferers (Arias-Vasquez et  al. 2011; Rivero et  al. 
2013). Recent studies have shown that RNAi suppression 
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Fig. 8  Increased apoptosis in GN11 cells and interneurons. Immuno-
blots of total and phosphorylated forms of Akt, GSK3β and Gapdh 
(a), and CC3, Bcl2 and β-Catenin (b) in GN11 cells following over-
expression and loss of Cdh13. c, d Histograms show protein lev-
els relative to controls, with a reduction in the levels of  Pser473-Akt, 
 Pser9-GSK3β and the anti-apoptotic marker Bcl2 and concomitant 
increase in the level of CC3 following Cdh13 knockdown. Changes 
in expression levels of mRNA (e) and protein (f, g) of genes involved 
in the Pi3k/Akt pathway in interneurons following incubation with a 
dominant negative form of Cdh13 (Cdh13-Fc) as compared to con-
trol human IgG treated cells (*p < 0.01, **p < 0.001, ***p < 0.0001). 
Error bars indicate SEM
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of Cdh13 function in lower layer cortical neurons leads 
to aberrant axonal projections (Hayano et  al. 2014). Fur-
ther, adult Cdh13−/− mice display deficits in learning and 
memory due to alterations in hippocampal neuron function, 
similar to those observed in ADHD patients (Rivero et al. 
2015).
The neurological phenotypes observed in the adult 
Cdh13−/− mice reported by Rivero et al. (2015) could have 
arisen from defects in corticogenesis. Thus, to explore this 
idea further, we carried out a thorough examination of the 
expression pattern of Cdh13 and neuronal phenotype(s) in 
Cdh13−/− mice during cortical development. Our analysis 
showed that Cdh13 is not present in interneurons during 
the early phase (E13.5) of corticogenesis. This finding is 
in disagreement with our previous microarray study where 
we showed expression of Cdh13 in the PPL (Antypa et al. 
2011). However, interneurons were not purified from the 
isolated PPL in this study, so it is possible that other cells 
or blood vessels, which appear to express Cdh13, could 
have been isolated together with interneurons, thus contam-
inating the sample.
During mid-stages of corticogenesis, Cdh13 is highly 
expressed in pyramidal neurons in the CP and along axons 
in the IZ, but not in interneurons. This is in agreement with 
our knockout data where we failed to detect any significant 
change in the number or positioning of interneurons or in 
early-born pyramidal cells. At E18.5, Cdh13 is expressed 
more strongly and broadly throughout the cortex, includ-
ing pyramidal neurons in the CP and some interneurons. At 
this age we found fewer late-born pyramidal neurons and 
interneurons in the cortex of Cdh13−/− mice, especially in 
the CP, indicating that Cdh13 has a role to play in cortical 
development.
We hypothesized that the reduction in the number of 
both cortical cell types could be due to various factors 
including altered migration, proliferation or apoptosis. 
At E15.5, we did not observe any changes in the num-
ber of cortical interneurons in Cdh13−/− mice compared 
to controls or in the migration of GN11 cells following 
Cdh13 knockdown, implying that defects in migration 
were unlikely to be responsible for their altered number at 
E18.5. An effect on migration could be indirect, as several 
previous studies have shown that changes in thalamocorti-
cal and corticothalamic projections can affect interneuron 
migration (Abe et  al. 2015; Andrews et  al. 2006; Denaxa 
et al. 2001). However, our L1 staining failed to show any 
gross differences in axonal projections in mice lacking 
the cadherin, but more detailed DiI/DiA tracing studies 
are required to assess more accurately these projections 
and their possible role in interneuron migration. Moreo-
ver, results of the in vitro Boyden’s assay show that block-
ing Cdh13 function in interneurons or its presence in the 
underlying substrate does not affect their ability to migrate. 
Taken together, these findings imply that Cdh13 is unlikely 
to play a role in interneuron migration, and that the changes 
observed in the cortex of Cdh13−/− mice at E18.5 are likely 
due to effects on proliferation and/or apoptosis.
Previously, it was shown that overexpression of Cdh13 
in HUVEC and human SMC cells resulted in increased 
proliferation (Ivanov et  al. 2004a). Based on this finding, 
we predicted that Cdh13 knockdown would decrease pro-
liferation, resulting in the generation of fewer interneurons, 
thus explaining the observed cortical phenotype. However, 
we failed to detect expression of Cdh13 in the proliferative 
zones during interneuron generation, suggesting that altered 
proliferation is unlikely the cause for the observed reduc-
tion in cortical interneuron numbers. This was confirmed 
in in vitro knockdown experiments using MGE progenitors 
or GN11 cells where we failed to detect an effect on prolif-
eration. However, we did observe a small increase in pro-
liferation in the proliferative zones of the MGE in vivo, but 
no changes in interneuron numbers in the cortex at E15.5. 
Since, loss of Cdh13 function does not appear to signifi-
cantly affect either migration or proliferation; it raises the 
possibility of a role for this gene in apoptotic events.
Programmed cell death plays a profound role in brain 
development, including the formation of the cortex. It has 
been documented that during early postnatal stages, both 
excitatory and inhibitory neurons in the cortex undergo 
apoptosis (Thomaidou et al. 1997). Our finding of increased 
apoptosis in the cortex at E18.5 concurs with existing stud-
ies on Cdh13 function which suggest a role in the regula-
tion of apoptosis through multiple pathways (Bosserhoff 
et al. 2014; Joshi et al. 2007, 2005; Philippova et al. 2008). 
The circulating, adipocyte-secreted hormone adiponectin 
(APN) has been shown to exert a protective effect in the 
heart and vasculature under stress conditions, through its 
association with Cdh13 and activation the AMPK path-
way (Denzel et  al. 2010; Parker-Duffen et  al. 2013). In 
the model of cultured endothelial cells (EC), Kyriakakis 
et al. (2010) have shown that up-regulation of Cdh13 dur-
ing endoplasmic reticulum (ER) stress attenuates the acti-
vation of the pro-apoptotic PERK branch of the unfolded 
protein response cascade and, thereby, protect EC from ER 
stress-induced apoptosis. Thus, it is conceivable that sig-
nalling pathways similar to those activated by APN and/or 
the UPR play a role in Cdh13 apoptotic events within the 
developing cortex. Further studies are required to evaluate 
these possibilities.
A recent study by Southwell and colleagues found that 
40% of cortical interneurons were eliminated through Bax- 
(Bcl-2 associated X-) dependent apoptosis in postnatal life 
(Southwell et  al. 2012). Interestingly, the proportion of 
interneurons lost in the Cdh13−/− cortex (~36%) is broadly 
similar to that reported by these authors, suggesting a pre-
cocious occurrence of these events. Such a role is likely, as 
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a recent study has shown that induced expression of Cdh13 
in melanoma cells resulted in the detection of V-Akt and 
FoxO3a hypophosphorylation, which was accompanied by 
the down-regulation of the ant-apoptotic molecules BCL-2 
and BCL-x, suggesting that Cdh13 regulates Akt signal-
ling and desensitizes melanoma cells to apoptosis (Bosser-
hoff et  al. 2014). Such a protective role was confirmed 
in in  vitro studies, where we found altered levels of Akt/
GSKβ signalling and reduced levels of Bcl2 and increased 
apoptosis following Cdh13 knockdown (Fig. 9). Thus, it is 
likely that Cdh13 signalling via Akt/GSKβ and Bcl-2 plays 
an important part in regulating the intrinsic timing mecha-
nisms involved in interneuron cell death and survival.
In summary, we report here that the majority of corti-
cal interneurons and pyramidal cells express Cdh13 at late 
stages of corticogenesis. Absence of this receptor leads 
to prenatal reduction in the number of both neuronal cell 
types. This decrease does not appear to be due to defects 
in migration or neurogenesis, but rather to increased apop-
tosis. These results implicate Cdh13 in the regulation of 
programmed cell death and survival in the developing fore-
brain that is prerequisite for the assembly of functional neu-
ronal circuits.
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